MIND Prize Initiative supports early-to-mid-career investigators pursuing bold brain research to advance understanding, prediction, prevention, and treatment of neurodegenerative diseases.
Funder: Pershing Square Philanthropies
Due Dates (Anticipated): September 2027 (Letter of Intent)
Funding Amounts: $750,000 over three years ($250,000 per year); generally at least six prizes annually
Summary: Supports early-to-mid-career investigators pursuing bold, hypothesis-driven research to advance understanding, prediction, prevention, and treatment of neurodegenerative diseases.
Key Information: Applicants need 1–8 years of independent research experience at award start and a qualifying U.S. nonprofit research appointment.
The MIND (Maximizing Innovation in Neuroscience Discovery) Prize is The Pershing Square Foundation’s brain research initiative. It supports early-to-mid-career investigators pursuing scientifically sound, high-risk, high-reward basic and translational research. The goal is to advance understanding of brain biology and cognition and transform approaches to neurodegenerative and neurocognitive disorders, particularly Alzheimer’s disease and dementias.
The prize encourages interdisciplinary approaches and collaboration across departments and institutions. Research may involve neurobiology, brain imaging and mapping, machine learning, drug delivery, or synthetic biology. Technology development must test a clearly defined biological hypothesis, and screening cannot be the sole focus. Clinical components are permitted, but projects centered on clinical trials or medical-device testing in humans are outside scope. Investigators with or without neuroscience training are encouraged to apply.